Miyuki Ota

596 total citations
27 papers, 470 citations indexed

About

Miyuki Ota is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Miyuki Ota has authored 27 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Miyuki Ota's work include Neuroscience and Neuropharmacology Research (6 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Regulation of Appetite and Obesity (3 papers). Miyuki Ota is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Regulation of Appetite and Obesity (3 papers). Miyuki Ota collaborates with scholars based in Japan, United States and Russia. Miyuki Ota's co-authors include Makoto Naoi, Tsutomu Takahashi, Wakako Maruyama, Daiichiro Nakahara, Toshiharu Nagatsu, Akira Nakashima, Akira Ota, Yoko Kaneko, Markku Linnoila and Milad S. Bitar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Journal of Neurochemistry.

In The Last Decade

Miyuki Ota

27 papers receiving 459 citations

Peers

Miyuki Ota

CMN

NEURO

PHYSI

PHARM

Mika Yamaguchi Japan

Nurgul Carkaci‐Salli United States

Qi Cheng Australia

Mia Engström Finland

Rie Kanki Japan

Jitendra Singh India

Toshikiyo Shohmori Japan

Jyrki Rintala Finland

M. Fujiwara Japan

Marcella Funicello Italy

Mika Yamaguchi Japan

Miyuki Ota

209 ×1.2

CMN

173 ×1.2

167 ×1.4

NEURO

121 ×2.2

PHYSI

61 ×1.1

PHARM

Citations per year, relative to Miyuki Ota Miyuki Ota (= 1×) peers Mika Yamaguchi

Countries citing papers authored by Miyuki Ota

Since Specialization

Citations

This map shows the geographic impact of Miyuki Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Ota more than expected).

Fields of papers citing papers by Miyuki Ota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Ota. The network helps show where Miyuki Ota may publish in the future.

Co-authorship network of co-authors of Miyuki Ota

This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Ota. A scholar is included among the top collaborators of Miyuki Ota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Ota. Miyuki Ota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kagami, Masayo, Miyuki Ota, Kentaro Matsuoka, et al.. (2019). Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR. Clinical Epigenetics. 11(1). 42–42. 18 indexed citations

Ota, Miyuki, et al.. (2019). A Case of Ixekizumab-induced Psoriasiform Eruption. Acta Dermato Venereologica. 99(4). 446–447. 8 indexed citations

Kaneko, Satoshi, Hiroshi Nagasaki, Akira Nakashima, et al.. (2016). Serotonin 5-HT2B receptor antagonism is fundamental for protecting PC12 cells exposed to hydrogen peroxide. SHILAP Revista de lepidopterología. 1 indexed citations

Kaneko, Yoko, Hiroshi Nagasaki, Akira Nakashima, et al.. (2014). Aripiprazole increases NAD(P)H–quinone oxidoreductase-1 and heme oxygenase-1 in PC12 cells. Journal of Neural Transmission. 122(6). 757–772. 5 indexed citations

Nagasaki, Hiroshi, Akira Nakashima, Yoko Kaneko, et al.. (2013). Aripiprazole increases NADPH level in PC12 cells: the role of NADPH oxidase. Journal of Neural Transmission. 121(1). 91–103. 9 indexed citations

Ota, Akira, Akira Nakashima, Yoko Kaneko, et al.. (2012). Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells. Journal of Neural Transmission. 119(11). 1327–1342. 10 indexed citations

Ota, Miyuki, Akira Nakashima, Yoko Kaneko, et al.. (2010). Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase. Journal of Neural Transmission. 117(10). 1139–1153. 14 indexed citations

Ota, Miyuki, et al.. (2006). Risperidone reduces mRNA expression levels of Sulfonylurea Receptor 1 and TASK1 in PC12 cells. Neuroscience Letters. 412(3). 254–258. 5 indexed citations

Ota, Miyuki, Keiji Mori, Akira Nakashima, et al.. (2005). RESISTANCE TO EXCESSIVE BODYWEIGHT GAIN IN RISPERIDONE‐INJECTED RATS. Clinical and Experimental Pharmacology and Physiology. 32(4). 279–287. 22 indexed citations

10.

Hirata, Sumío, et al.. (2004). Adjustment of Valacyclovir Dosage for Herpes Zoster Infection in Patients Undergoing Hemodialysis. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 30(8). 547–552. 3 indexed citations

11.

Hirata, Sumío, et al.. (2004). A survey of constipation in dialysis patients. Nihon Toseki Igakkai Zasshi. 37(10). 1887–1892. 4 indexed citations

12.

Hirata, Sumío, et al.. (2003). Elevated Serum Vancomycin Concentrations After Oral Administration in a Hemodialysis Patient with Pseudomembranous Colitis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 34(3). 87–90. 8 indexed citations

13.

Hirata, Sumío, et al.. (2002). . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 33(6). 277–279. 2 indexed citations

14.

Ota, Miyuki, Akira Nakashima, Yoko Kaneko, et al.. (2002). Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats. Clinical and Experimental Pharmacology and Physiology. 29(11). 980–989. 57 indexed citations

15.

Naoi, Makoto, Wakako Maruyama, P. Dostert, et al.. (1996). Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Research. 709(2). 285–295. 89 indexed citations

16.

Matsubara, Kazuo, Miyuki Ota, Tsutomu Takahashi, Wakako Maruyama, & Makoto Naoi. (1994). Structural studies of condensation products of biogenic amines as inhibitors of trytophan hydroxylase. Brain Research. 655(1-2). 121–127. 9 indexed citations

17.

Maruyama, Wakako, Daiichiro Nakahara, Miyuki Ota, et al.. (1992). N‐Methylation of Dopamine‐Derived 6,7‐Dihydroxy‐1,2,3,4‐Tetrahydroisoquinoline, (R)‐Salsolinol, in Rat Brains: In Vivo Microdialysis Study. Journal of Neurochemistry. 59(2). 395–400. 82 indexed citations

18.

Naoi, Makoto, Syun Hosoda, Miyuki Ota, Tsutomu Takahashi, & Toshiharu Nagatsu. (1991). Inhibition of tryptophan hydroxylase by food-derived carcinogenic heterocyclic amines, 3-amino-1-methyl-5H-pyrido[4,3-b]indole and 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole. Biochemical Pharmacology. 41(2). 199–203. 14 indexed citations

19.

Bitar, Milad S., Miyuki Ota, Markku Linnoila, & Bernard H. Shapiro. (1991). Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psychoneuroendocrinology. 16(6). 547–557. 57 indexed citations

20.

Mefford, Ivan N., Richard G. Lister, Miyuki Ota, & Markku Linnoila. (1990). Antagonism of Ethanol Intoxication in Rats by Inhibitors of Phenylethanolamine N‐Methyltransferase. Alcoholism Clinical and Experimental Research. 14(1). 53–57. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact